id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-0002,FDA,FDA-2007-D-0369,Publication of Guidances for Industry Describing Product-Specific Bioequivalence Recommendations,Notice,NAD-Notice of Availability of Data,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2007-12-25T04:59:59Z,2008-05-20T19:33:47Z,,0,0,090000648042bb9e
FDA-2007-D-0369-0001,FDA,FDA-2007-D-0369,Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,Notice,NAD-Notice of Availability of Data,2007-06-06T04:00:00Z,2007,6,2007-05-30T04:00:00Z,2007-09-29T03:59:59Z,2015-03-14T02:01:49Z,,0,0,090000648042bb8c